Britain's NHS to trial ‘superhuman’ AI system that predicts early death risk

Anyone who has an ECG anywhere in the NHS in five or 10 years will be assessed using the technology

A patient ready for an electrocardiogram test. The UK's NHS will collect heart data for analysts using AI which will provide insights into possible dangers patients may face. Getty

The UK's National Health Service is set to test a new artificial intelligence model that is designed to predict a patient’s risk of disease and early death.

The technology uses the readings of a common and easily available heart test to alert doctors to patients who may benefit from further tests or treatment. The programme will be launched next year and will be used across the NHS within five years.

The AI-ECG risk estimation, or Aire, was developed to assess the results of electrocardiogram (ECG) tests, which record the electrical activity of the heart and are given to patients suspected of having heart problems.

It then uses these recordings to detect problems with the structure of the heart that doctors would not be able to see.

The technology will be tested at Imperial College Healthcare NHS Trust and Chelsea and Westminster Hospital NHS Foundation Trust from the middle of 2025, with other hospital sites to be confirmed.

“There are three or four different studies that are going to run across hospitals from the middle of next year,” Dr Fu Siong Ng, a reader in cardiac electrophysiology at Imperial College London and consultant cardiologist at Imperial College Healthcare NHS Trust, said.

“They are broadly to test that these models are accurate in diagnoses. So, people who would already have an ECG at the hospital, we would test that these models are accurate in picking up certain diagnoses.

“Then, the next layer, once that’s been shown, we can intervene to show that we can change the trajectory of the patients.”

Foods that are good for heart health – in pictures

It is understood several hundred patients will be recruited for the first trial, with numbers then increased for following studies.

“The vision is every ECG that will be done in hospital will be put through the model,” Dr Ng added.

“So, anyone who has an ECG anywhere in the NHS in 10 years’ time, or five years’ time, would be put through the models and the clinicians will be informed, not just about what the diagnosis is, but a prediction of a whole range of health risks, which means that we can then intervene early and prevent disease.

“If, for example, it says you’re at high risk of a specific heart rhythm problem, you could be more aggressive in preventive treatment to stop it from happening. There are some linked to weight, so you can put those patients through weight loss programmes.

“You might even think about earlier medical treatments to prevent things from progressing, but that will be the subject of the clinical studies that we plan to do.”

Dr Arunashis Sau, a British Heart Foundation (BHF) clinical research fellow at Imperial College London’s National Heart and Lung Institute and cardiology registrar at Imperial College Healthcare NHS Trust, said the aim of the Aire is not to develop something to replace doctors, but to create something “superhuman”.

“The goal here is to try to use the ECG as a way to identify people that are at higher risk, who will then maybe benefit from other tests that could tell us more about what’s going on,” he said.

“ECG is a very common and very cheap test, but that could then be used to guide more detailed testing that could then change how we manage patients and potentially reduce the risk of anything bad happening.

“One key distinction is that the goal here was to do something that was superhuman – so not replace or speed up something that a doctor could do, but to do something that a doctor cannot do from looking at heart tracing.”

Research published in Lancet Digital Health found Aire was able to correctly identify a patient’s risk of death in the 10 years following the ECG, from high to low, in 78 per cent of cases.

For the study, the team trained Aire using a data set of 1.16 million ECG test results from 189,539 patients.

The platform could also predict heart failure in 79 per cent of cases, serious heart rhythm problems in 76 per cent of cases, and atherosclerotic cardiovascular disease – where the arteries narrow, making blood flow difficult – in 70 per cent of cases.

“We know that not only doctors, but patients, need to trust AI. And that’s a big part of the work that we did here,” Dr Sau said.

“What we found is that AI could pick up things to do with the patient’s heart structure and function, and even things as deep as genetic information were being picked up that the AI could be using in combination to find out that these people might be at higher risk, and these are things that are not apparent to human clinicians.”